NEW YORK STOCK EXCHANGE, INC. · RCUS
+2.18% · +$0.6300 · Vol 1.2M
Market closed · last close 4:00 PM ET · price as of 19:01:41 ET
Arcus Biosciences Inc

Arcus Biosciences Inc

Biotechnology
$29.49
Card
Relationship Map

Veridion Score

BETALOW CONF · 6/6 factorsMethodology
RCUS
Arcus Biosciences Inc
Sun Aug 16 · completed session · Markets closed · resumes Mon 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

56/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 6/6 factors with data · Sun Aug 16 · completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is RCUS moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading RCUS catalysts
About Arcus Biosciences Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2018
Employees
601
Country
US

Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$28.55
Day high
$29.68
Day low
$27.97
Previous close
$28.86
52W high
$31.08
-5.12% from high
52W low
$10.06
92% of range
Market cap
$3.8B
EPS
$-3.0100
Beta
1.55
Shares out
127.3M
Volume
1.2M
1.09× rel vol
Avg volume
1.1M
VWAP
$29.19
Price history computed in-house
1W
+2.68%
1M
+7.75%
3M
+29.63%
1Y
+183.83%
YTD
+23.75%
SMA 50 $27.68 · above
SMA 200 $23.86 · above
52W position 92%

RCUS overview

Veridion Score
56
Daily close · 2026-08-14
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around RCUS.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading RCUS Form 4 filings
Public disclosures

Congress activity in RCUS

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for RCUS in the cached public ledger.

Federal contracts

RCUS contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for RCUS in this window.
Lobbying spend

RCUS lobbying filings, year to date.

Registered lobbying filings matched to Arcus Biosciences Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for RCUS in this window.
Loading news for RCUS
Analyst ratings
Sovereign unlock shows live analyst consensus for RCUS.
Options
Sovereign unlock shows live options positioning for RCUS.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.